Medical and entrepreneurial character of the community pharmacy

Czech version

Authors: Ivona Malovecká; Igor Minarovič; Daniela Mináriková; Miroslava Snopková; Ľubica Lehocká; Viliam Foltán
Published in: Čes. slov. Farm., 2014; 63, 84-89
Category: Original Articles

Overview

Community pharmacy provides citizens with pharmaceutical care and runs its health care business on the market with state regulatory interventions. These restrictions affect its stability and because of that it has to be constantly monitored. The convenient way of monitoring the financial health of a community pharmacy is the use of financial analysis and its outcomes that are profitability, liquidity, debt and productivity ratios. The aim of this paper was to determine the economic situation in the public pharmacy services in Slovakia. A representative set of community pharmacies was established that reflected the criteria of localization by regions in Slovakia, the size of the city or municipality and the legal form of the subject. The financial analysis for the years 2007–2012 showed a declining return on sales (in 2012 to 1.98 %), a decreasing current liquidity (in 2012 to 1.87 %), a declining quick ratio (in 2012 to 1.08 %), a decrease in the time receivables turnover (in 2012 to 53.8 days), a slight increase in the inventory turnover time – days sales in inventory (in 2012 to 36.5 days) and increased turnover time commitments – liabilities turnover (in 2012 to 86.3 days).

Keywords:
community pharmacy • financial health • profitability • liquidity • productivity

Sources

1. PGEU. European Community Pharmacy Blueprint. Pharmaceutical Group of European Union; 2012 [online] [cit. 2013-09-27] http://www.pgeu.eu/en/downloads/1729.html.

2. Zákon NR SR č.362/2011 Z. z. o liekoch a zdravotníckych pomôckach [online] [cit. 2013-09-27], www.zbierka.sk/ sk/predpisy/362-2011-z-z.p-34324.pdf‎.

3. Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy 2005; 75(1): 9–17 [online] [cit. 2013-09-27] http://www.ncbi.nlm.nih.gov/pubmed/16298225

4. Vlachynský K. a kol. Podnikové financie. Bratislava: Ekonómia; 2009.

5. Executive Agency for Health and Consumers (EAHC). Survey of Chain of Trust Project, under EU Public Health Programme (Grant Agreement N° 2009 11 13). 2011 [online] [cit. 2013-05-05] http://www.chainoftrust.eu.

6. Goldman D. P., Joyce G. F., Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007; 298(1): 61–69. [online] [cit. 2013-09-27] http://www.ncbi.nlm.nih.gov/pubmed/17609491.

7. Lisý J. a kol. Ekonómia v novej ekonomike. Bratislava: Iura Edition 2005.

8. Sedláček J. Finanční analýza podniku. Brno: Computer Press 2007.

9. Kislingerová E. Manažerské finance. Praha: C. H. Beck 2010.

10. UZIŠ. Zdravotnícka ročenka Slovenskej republiky 2000. Ústav zdravotníckych informácií a štatistiky; 2001 [online] [cit. 2013-10-03].

http://www.nczisk.sk/Documents/rocenky/rocenka_2000.pdf.

11. Zdravotnícka ročenka Slovenskej republiky 2010. Národné centrum zdravotníckych informácií 2011 [online] [cit. 2013-10-03], http://www.nczisk.sk/Documents/rocenky/rocenka_2010.pdf.

12. IPU. Statement from the Irish Pharmacy Union. Irish Pharmacy Union 2013 [online] [cit. 2013-09-27], http://ipu.ie/component/content/article/307-archived-news/998-statement-from-the-irish-pharmacy-union.html.

13. KordaMentha. Retail pahrmacy – ready to take their medicine? KordaMentha 2011 [online] [cit.2013-09-27], http://www.kordamentha.com/docs/publications/publication-11-03-retail-pharmacy.pdf?Status=Master.

14. NCPA. 2009 NCPA Digest. National Community Pharmacist Association 2010 [online] [cit. 2013-05-05], http://www.ncpanet.org/pdf/digest/ExecutiveSummary09Digest.pdf.

15. Grootendorst P., Rocchi M., Segal H. An economic analysis of the impact of reductions in generic drug rebates on community pharmacy in Canada. 2008 [online] [cit. 2013-09-27] http://individual.utoronto.ca/grootendorst/pdf/Grootendorst_et_al_Pharmacy_Rebates_Report_Final.pdf.

16. ATKearney. The future of community pharmacy in England. ATKearney 2012 [online] [cit. 2013-09-27], http://www.atkearney.com/documents/10192/649132/The+Future+ of+Community+Pharmacypdf/1838dede-b95a-4989-8600-6b435bd00171.

Labels

Pharmacy Clinical pharmacology

Possibilities of influencing the drug content and encapsulation efficiency of chitosan microspheres prepared by ionic gelation process

History of the development and production of drugs in the firm Lachema in Brno

Selected natural phenolic compounds – potential treatment for peripheral neuropathy?

Active pharmaceutical ingredients available as substances for extemporaneous preparation in veterinary medicine in the Czech Republic

Article was published in

Czech and Slovak Pharmacy

2014 Issue 2